We are live on
!
Find out more
Lazard Asset Management Portfolio holdings
AUM
$60.8B
1-Year Est. Return
22.47%
This Fund
S&P 500
This Quarter
Est. Return
+14.09%
1 Year Est. Return
+22.47%
3 Year Est. Return
+62.53%
5 Year Est. Return
+77.87%
10 Year Est. Return
+305.76%
AUM
$79.1B
AUM Growth
+$7.99B
(+11%)
Cap. Flow
-$5.86B
Cap. Flow
% of AUM
-7.4%
Top 10 Holdings %
Top 10 Hldgs %
22.63%
Holding
2,061
New
445
Increased
504
Reduced
465
Closed
231
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sysco
SYY
|
+$273M |
| 2 |
Waste Management
WM
|
+$168M |
| 3 |
Lowe's Companies
LOW
|
+$160M |
| 4 |
PNC Financial Services
PNC
|
+$154M |
| 5 |
Unilever
UL
|
+$122M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$548M |
| 2 |
Apple
AAPL
|
+$372M |
| 3 |
CSX Corp
CSX
|
+$369M |
| 4 |
Infosys
INFY
|
+$238M |
| 5 |
Kimberly-Clark
KMB
|
+$235M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.16% |
| 2 | Healthcare | 14.65% |
| 3 | Financials | 13.08% |
| 4 | Industrials | 9.66% |
| 5 | Consumer Discretionary | 9.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
776
iShares S&P 500 Growth ETF
IVW
$77.6B
| $763K | ﹤0.01% |
11,960
| – | – |
|
|
APLS
777
DELISTED
Apellis Pharmaceuticals
APLS
| $754K | ﹤0.01% |
+13,189
| New | +$558K |
|
778
Dropbox
DBX
$8.12B
| $748K | ﹤0.01% |
33,738
| – | – |
|
779
First Majestic Silver
AG
$9.07B
| $747K | ﹤0.01% |
55,636
-28,002
| -33% | -$308K |
|
780
Goldman Sachs
GS
$303B
| $745K | ﹤0.01% |
2,827
-8
| -0.3% | -$1.78K |
|
|
UFS
781
DELISTED
DOMTAR CORPORATION (New)
UFS
| $740K | ﹤0.01% |
23,396
+11,370
| +95% | +$324K |
|
|
PRSP
782
DELISTED
Perspecta Inc. Common Stock
PRSP
| $736K | ﹤0.01% |
30,600
| – | – |
|
783
Nasdaq
NDAQ
$52.9B
| $732K | ﹤0.01% |
16,575
-44,232
| -73% | -$1.87M |
|
784
Incyte
INCY
$24.4B
| $728K | ﹤0.01% |
8,376
-14,369
| -63% | -$1.24M |
|
|
GLDD
785
DELISTED
Great Lakes Dredge & Dock
GLDD
| $726K | ﹤0.01% |
55,145
+47,619
| +633% | +$533K |
|
786
Collegium Pharmaceutical
COLL
$956M
| $723K | ﹤0.01% |
36,121
+3,946
| +12% | +$77K |
|
787
Darling Ingredients
DAR
$9.44B
| $711K | ﹤0.01% |
12,329
+11,297
| +1,095% | +$540K |
|
|
ATCO
788
DELISTED
Atlas Corp.
ATCO
| $710K | ﹤0.01% |
+65,500
| New | +$673K |
|
789
PRA Group
PRAA
$755M
| $708K | ﹤0.01% |
+17,852
| New | +$708K |
|
790
Penumbra
PEN
$12.8B
| $704K | ﹤0.01% |
4,025
| – | – |
|
|
ENV
791
DELISTED
ENVESTNET, INC.
ENV
| $697K | ﹤0.01% |
+8,471
| New | +$683K |
|
792
Snap
SNAP
$9.01B
| $683K | ﹤0.01% |
13,673
+8,169
| +148% | +$339K |
|
793
Veeco
VECO
$3.23B
| $683K | ﹤0.01% |
+39,380
| New | +$602K |
|
794
Louisiana-Pacific
LPX
$5.49B
| $679K | ﹤0.01% |
18,282
+8,720
| +91% | +$292K |
|
795
Cardlytics
CDLX
$21.5M
| $657K | ﹤0.01% |
+460
| New | +$491K |
|
796
Church & Dwight Co
CHD
$24.5B
| $630K | ﹤0.01% |
7,233
-347,924
| -98% | -$30.8M |
|
797
Phillips 66
PSX
$81.4B
| $627K | ﹤0.01% |
8,982
-2,032
| -18% | -$119K |
|
|
EVBG
798
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $625K | ﹤0.01% |
+4,193
| New | +$536K |
|
799
iShares Russell Mid-Cap Growth ETF
IWP
$20.7B
| $624K | ﹤0.01% |
6,086
+2,486
| +69% | +$237K |
|
800
Paychex
PAYX
$42.7B
| $620K | ﹤0.01% |
6,664
+2,003
| +43% | +$178K |
|
Similar funds
QCM
Lazard Asset Management's Q4 2020 Portfolio in Review
As of Q4 2020, Lazard Asset Management held 2,061 positions worth $79.1B, up 11% from $71.1B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Lazard Asset Management withdrew a net $5.86B in Q4 2020, closing 231 positions and reducing 465 holdings. Its most notable exit was Unilever NV New York Registry Shares, an estimated $112M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Lazard Asset Management opened a new position in Sotera Health worth $100M.
- Lazard Asset Management's largest Q4 2020 buy was Sotera Health: 3,651,831 shares worth $100M.
- Lazard Asset Management added most to Sysco in Q4 2020, an estimated $273M increase.
- Lazard Asset Management's biggest Q4 2020 reduction was Pfizer, cutting an estimated $548M.
- Lazard Asset Management fully exited Unilever NV New York Registry Shares in Q4 2020, selling an estimated $112M.
- Lazard Asset Management's ten largest holdings make up 23% of its $79.1B portfolio in Q4 2020.
- Lazard Asset Management opened 445 new positions and closed 231 in Q4 2020.
- Lazard Asset Management's portfolio value rose 11% quarter-over-quarter to $79.1B.
Based on Lazard Asset Management's 13F filing for Q4 2020, filed 11 Feb 2021.